Coherus Oncology Inc (CHRS)

SG&A Expense Growth

-34.19%

Fiscal year · Period ending:

CHRS logo

CHRS SG&A Expense Growth

Latest reported-34.19%
CHRS FY SG&A Growth (YoY) (0.00% → -34.19%)
High-resolution chart · PNG

CHRS sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
-34.1895%
-18.9516%
-6.4822%
16.951%
22.0263%
1.4901%
45.5101%
32.08%
38.1921%
43.1421%
105.2266%
135.2847%
34.9666%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.